Luton, Bedfordshire, United Kingdom, Nov. 15, 2024 (GLOBE NEWSWIRE) -- The global cardiac device market is experiencing tremendous growth. This is driven by the increasing prevalence of chronic heart ...
Cardiovascular (CV) disease is commonly observed in individuals with type 2 diabetes (T2D) and is associated with significant morbidity and mortality. Diabetes medications can have substantial ...
In a recent review published in the Canadian Journal of Cardiology, researchers discussed the association between cardiovascular health and the exposome, which comprises the cumulative impact of ...
This quality standard covers identifying and assessing cardiovascular risk in adults (aged 18 and over) and treatment to prevent cardiovascular disease. It describes high-quality care in priority ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Despite updated treatment guidelines, a prevalent gap ...
As new therapies improve survival from cancer, attention to comorbid illness and complications of therapy—both short- and long-term—become much more important to improving not only quality of life but ...
Delve into the cutting-edge world of Cardiovascular-Kidney-Metabolic (CKM) Syndrome management in this CKM Dialogues previously recorded LIVE. This dynamic, expert-led, evidence-driven CME activity ...
Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Personalized Medicine Market - Types, Technologies and Applications" report has been added to ResearchAndMarkets.com's offering. The global Personalized ...
Cardiovascular disease (CVD) is the leading cause of death and a major cause of disability worldwide. In the United States, CVD accounted for 34.4 percent of the 2.4 million deaths in 2003 and remain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback